PAR

5.00%

19.0¢ paradigm biopharmaceuticals limited..

most of us are too heavily invested and down on our investment...

First 52 Last

Share
Profile

Follow
bobsee

287 Posts.

39

06/04/24

16:02

Post #: 73220785
Share

Originally posted by 39KP: ↑

I get it that no news + low cash + shares at 33c cause concern. but why are people saying that we are going bust in 6 weeks ?

they are getting a peer review as promised

they are trying to get the dose approved

they are trying to sort funding.

they are speaking to partners

given they have lots of data to show the fda (is this a bad thing ?) the fda have asked for a different pathway and will revert in June hopefully.

if people expect daily updates they are mistaken. if you think shares going down when Nasdaq / S&P have the worst day in 6 months is cause for concern then ok, but I don't see what it has to do with par or any other small cap I own.

is any big fund buying bc we are at 10% of our highs ? no. they are professionals and don't take punts. they will wait for the fda decision/ tga / peer review / breakthrough or whatever is coming down the pipe.

I am not saying all is well and this stock is going to the moon. I am just saying let's focus on the fact that they are discussing right now with the fda etc. if we don't get 2x2 and if we can't get cash etc then I will probably sell too. but am I selling because simon and Paul are not telling us regularly exactly what they are up to ? no

it seems this forum is either high as a kite or near suicidal.

everyone says these guys are incompetent etc etc etc. Apple just shut down their car project after 5+ years and billions of dollars. sometimes it doesn't work out. even for the best.

par is taking longer than we all hoped. are they morons ? I don't know, is Tim Cook a moron ? I say no.

I could go on but if you don't like the quiet periods / if u don't like management/ If u think they are going bust then sell.

why anyone would stay invested and spend time on HC if they think a company has 60/90 days to survive is beyond me

Expand

most of us are too heavily invested and down on our investment to get out now...too late...just hope theres a turnaround soon.

PAR Price at posting: 33.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The winners & losers on market if negative gearing were gone

There are more pages in this discussion • 655 more messages in this thread...

First 52 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 19.0¢		Change -0.010(5.00%)		Mkt cap ! $66.54M

Open	High	Low	Value	Volume
20.0¢	21.0¢	19.0¢	$203.4K	1.019M

Buyers (Bids)

No.	Vol.	Price($)
14	387930	19.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	65468	2

View Market Depth

No.	Vol.	Price($)
13	384246	0.190
3	57000	0.185
8	194873	0.180
6	140904	0.175
7	595605	0.170

Price($)	Vol.	No.
0.205	65468	2
0.210	25992	3
0.215	30000	1
0.220	27066	4
0.225	21604	2

Last trade - 16.10pm 27/09/2024 (20 minute delay)

PAR (ASX) Chart

most of us are too heavily invested and down on our investment...

The market's shrugged at China's stimulus measures all year. Why is this one different?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACCC seeks Olam divestments before it can buy Namoi Cotton

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The winners & losers on market if negative gearing were gone

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

most of us are too heavily invested and down on our investment...

Top Stories

The market's shrugged at China's stimulus measures all year. Why is this one different?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACCC seeks Olam divestments before it can buy Namoi Cotton

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The winners & losers on market if negative gearing were gone

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News